These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
326 related articles for article (PubMed ID: 18722033)
1. Docking, 3D-QSAR studies and in silico ADME prediction on c-Src tyrosine kinase inhibitors. Tintori C; Magnani M; Schenone S; Botta M Eur J Med Chem; 2009 Mar; 44(3):990-1000. PubMed ID: 18722033 [TBL] [Abstract][Full Text] [Related]
2. Receptor-based 3D-QSAR studies of checkpoint Wee1 kinase inhibitors. Wichapong K; Lindner M; Pianwanit S; Kokpol S; Sippl W Eur J Med Chem; 2009 Apr; 44(4):1383-95. PubMed ID: 18976834 [TBL] [Abstract][Full Text] [Related]
3. 3-D QSAR studies on histone deacetylase inhibitors. A GOLPE/GRID approach on different series of compounds. Ragno R; Simeoni S; Valente S; Massa S; Mai A J Chem Inf Model; 2006; 46(3):1420-30. PubMed ID: 16711762 [TBL] [Abstract][Full Text] [Related]
4. 3D QSAR models built on structure-based alignments of Abl tyrosine kinase inhibitors. Falchi F; Manetti F; Carraro F; Naldini A; Maga G; Crespan E; Schenone S; Bruno O; Brullo C; Botta M ChemMedChem; 2009 Jun; 4(6):976-87. PubMed ID: 19326384 [TBL] [Abstract][Full Text] [Related]
5. Molecular modeling studies of phenoxypyrimidinyl imidazoles as p38 kinase inhibitors using QSAR and docking. Ravindra GK; Achaiah G; Sastry GN Eur J Med Chem; 2008 Apr; 43(4):830-8. PubMed ID: 17706839 [TBL] [Abstract][Full Text] [Related]
7. Combined 3D-QSAR modeling and molecular docking study on 1,4-dihydroindeno[1,2-c]pyrazoles as VEGFR-2 kinase inhibitors. Zeng H; Zhang H J Mol Graph Model; 2010 Aug; 29(1):54-71. PubMed ID: 20471293 [TBL] [Abstract][Full Text] [Related]
8. Potential choline kinase inhibitors: a molecular modeling study of bis-quinolinium compounds. Srivani P; Sastry GN J Mol Graph Model; 2009 Feb; 27(6):676-88. PubMed ID: 19147382 [TBL] [Abstract][Full Text] [Related]
9. 3D-QSAR studies on c-Src kinase inhibitors and docking analyses of a potent dual kinase inhibitor of c-Src and c-Abl kinases. Thaimattam R; Daga PR; Banerjee R; Iqbal J Bioorg Med Chem; 2005 Aug; 13(15):4704-12. PubMed ID: 15914012 [TBL] [Abstract][Full Text] [Related]
10. 3D-QSAR studies of Checkpoint Kinase Weel inhibitors based on molecular docking, CoMFA and CoMSIA. Yi P; Fang X; Qiu M Eur J Med Chem; 2008 May; 43(5):925-38. PubMed ID: 17698256 [TBL] [Abstract][Full Text] [Related]
12. QSAR studies on 4-anilino-3-quinolinecarbonitriles as Src kinase inhibitors using robust PCA and both linear and nonlinear models. Sun M; Zheng Y; Wei H; Chen J; Ji M J Enzyme Inhib Med Chem; 2009 Oct; 24(5):1109-16. PubMed ID: 19555174 [TBL] [Abstract][Full Text] [Related]
13. Combined 3D-QSAR modeling and molecular docking study on indolinone derivatives as inhibitors of 3-phosphoinositide-dependent protein kinase-1. AbdulHameed MD; Hamza A; Liu J; Zhan CG J Chem Inf Model; 2008 Sep; 48(9):1760-72. PubMed ID: 18717540 [TBL] [Abstract][Full Text] [Related]
14. Receptor-guided alignment-based comparative 3D-QSAR studies of benzylidene malonitrile tyrphostins as EGFR and HER-2 kinase inhibitors. Kamath S; Buolamwini JK J Med Chem; 2003 Oct; 46(22):4657-68. PubMed ID: 14561085 [TBL] [Abstract][Full Text] [Related]
15. Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function. Schormann N; Senkovich O; Walker K; Wright DL; Anderson AC; Rosowsky A; Ananthan S; Shinkre B; Velu S; Chattopadhyay D Proteins; 2008 Dec; 73(4):889-901. PubMed ID: 18536013 [TBL] [Abstract][Full Text] [Related]
16. 3D QSAR studies on a series of potent and high selective inhibitors for three kinases of RTK family. Cao H; Zhang H; Zheng X; Gao D J Mol Graph Model; 2007 Jul; 26(1):236-45. PubMed ID: 17293140 [TBL] [Abstract][Full Text] [Related]
17. Computational design of novel fullerene analogues as potential HIV-1 PR inhibitors: Analysis of the binding interactions between fullerene inhibitors and HIV-1 PR residues using 3D QSAR, molecular docking and molecular dynamics simulations. Durdagi S; Mavromoustakos T; Chronakis N; Papadopoulos MG Bioorg Med Chem; 2008 Dec; 16(23):9957-74. PubMed ID: 18996019 [TBL] [Abstract][Full Text] [Related]
18. 3D-QSAR studies of farnesyltransferase inhibitors: a comparative molecular field analysis approach. Puntambekar D; Giridhar R; Yadav MR Bioorg Med Chem Lett; 2006 Apr; 16(7):1821-7. PubMed ID: 16455255 [TBL] [Abstract][Full Text] [Related]
19. 3D QSAR studies of AChE inhibitors based on molecular docking scores and CoMFA. Akula N; Lecanu L; Greeson J; Papadopoulos V Bioorg Med Chem Lett; 2006 Dec; 16(24):6277-80. PubMed ID: 17049234 [TBL] [Abstract][Full Text] [Related]
20. Design of novel FLT-3 inhibitors based on dual-layer 3D-QSAR model and fragment-based compounds in silico. Shih KC; Lin CY; Chi HC; Hwang CS; Chen TS; Tang CY; Hsiao NW J Chem Inf Model; 2012 Jan; 52(1):146-55. PubMed ID: 22142286 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]